<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
    <channel>
        <title>Marketwire - Plastics and fibers</title>
        <link>http://www.marketwire.com</link>
        <description>Marketwire - Plastics and fibers</description>
        <language>en</language>
        <copyright>Copyright: (C) Marketwire</copyright>
        <lastBuildDate>Thu, 05 Nov 2009 12:34:00 EST</lastBuildDate>
        <ttl>1</ttl>
        <image>
            <title>Marketwire.com</title>
            <url>http://www.marketwire.com/rss/marketwire_logo.jpg</url>
            <link>http://www.marketwire.com</link>
        </image>
        <item>
            <title>CTI Industries Corporation Announces Presentation at the Wall Street Analyst Forum in New York City</title>
            <link>http://www.marketwire.com/mw/release.do?id=1071891&amp;sourceType=3</link>
            <description>&lt;p&gt;BARRINGTON, IL--(Marketwire - November 5, 2009) -  CTI Industries Corporation (&lt;exchange name="NASDAQ"&gt;NASDAQ&lt;/exchange&gt;: &lt;ticker name="CTIB"&gt;CTIB&lt;/ticker&gt;), a
manufacturer and marketer of metallized balloons, latex balloons, novelty
items, packaging and storage bags and pouches and printed and laminated
films, today announced that Stephen M. Merrick, the Company's Executive
Vice President, will present the Company's general business outlook with
investors and financial analysts on Thursday, November 19, 2009, at the
Wall Street Analyst Forum in New York City.
</description>
            <category domain="http://www.marketwire.com/rss/stock">NASDAQ:CTIB</category>
            <pubDate>Thu, 05 Nov 2009 12:00:00 EST</pubDate>
        </item>
        <item>
            <title>Agrium Makes Best and Final Offer for CF Industries of $45.00 Per Share in Cash Plus One Agrium Share</title>
            <link>http://www.marketwire.com/mw/release.do?id=1071539&amp;sourceType=3</link>
            <description>Urges CF stockholders to send clear message to CF board to accept Agrium's compelling final offer 

Receives "No-Action" letter from Canadian Competition Bureau and Re-files notification under Hart-Scott-Rodino</description>
            <category domain="http://www.marketwire.com/rss/stock">TSX:AGU</category>
            <category domain="http://www.marketwire.com/rss/stock">NYSE:AGU</category>
            <pubDate>Thu, 05 Nov 2009 07:15:00 EST</pubDate>
        </item>
        <item>
            <title>RAE Systems Reports Third Quarter 2009 Results</title>
            <link>http://www.marketwire.com/mw/release.do?id=1071264&amp;sourceType=3</link>
            <description>&lt;p&gt;Achieves Non-GAAP Profitability; Books an Accrual for Potential FCPA Settlement With DOJ &amp; SEC&lt;/p&gt;</description>
            <category domain="http://www.marketwire.com/rss/stock">NYSE Amex:RAE</category>
            <pubDate>Wed, 04 Nov 2009 16:10:00 EST</pubDate>
        </item>
        <item>
            <title>Clorox Announces Pricing of $300 Million Senior Notes</title>
            <link>http://www.marketwire.com/mw/release.do?id=1071217&amp;sourceType=3</link>
            <description>&lt;p&gt;OAKLAND, CA--(Marketwire - November 4, 2009) -  The Clorox Company (&lt;exchange name="NYSE"&gt;NYSE&lt;/exchange&gt;: &lt;ticker name="CLX"&gt;CLX&lt;/ticker&gt;) today announced
that it has priced an offering of $300 million aggregate principal amount
of its 3.55 percent senior notes due Nov. 1, 2015, in an underwritten
registered public offering. The offering was made pursuant to an effective
shelf registration statement Clorox filed with the Securities and Exchange
Commission (SEC) on Oct. 3, 2007, as amended on Nov. 4, 2009. The offering
is expected to close on Nov. 9, 2009, subject to customary closing
conditions. Clorox intends to use the net proceeds from the offering to
retire commercial paper.
</description>
            <category domain="http://www.marketwire.com/rss/stock">NYSE:CLX</category>
            <pubDate>Wed, 04 Nov 2009 15:24:00 EST</pubDate>
        </item>
        <item>
            <title>InFusion SCADA 2.0 Offering From Invensys Delivers New Functionality, Flexibility and Security for Remote Operations</title>
            <link>http://www.marketwire.com/mw/release.do?id=1070902&amp;sourceType=3</link>
            <description>&lt;p&gt;Comprehensive Solution Has RTUs for Oil &amp; Gas, Water &amp; Wastewater Applications&lt;/p&gt;</description>
            <pubDate>Wed, 04 Nov 2009 10:00:00 EST</pubDate>
        </item>
        <item>
            <title>Advanced Clean Technologies Retains WorldMarketMedia.com to Design and Implement Their Social Media Marketing Campaign</title>
            <link>http://www.marketwire.com/mw/release.do?id=1070740&amp;sourceType=3</link>
            <description>&lt;p&gt;HUNTINGTON BEACH, CA--(Marketwire - November 4, 2009) -  Advanced Clean Technologies, Inc.
(&lt;exchange name="PINKSHEETS"&gt;PINKSHEETS&lt;/exchange&gt;: &lt;ticker name="ACTH"&gt;ACTH&lt;/ticker&gt;) announces the retention of World Market Media, Inc. to
lead the Company's Social Media Marketing efforts.
&lt;p&gt;
Ronald P. Russo, Jr., Founder &amp; Social Equity Officer, states, "We are
delighted that the Advanced Clean Technologies management team has engaged
World Market Media to design and implement their Social Media Distribution
Plan and Platform."
</description>
            <pubDate>Wed, 04 Nov 2009 08:00:00 EST</pubDate>
        </item>
        <item>
            <title>Agrium Reports Third Quarter Results</title>
            <link>http://www.marketwire.com/mw/release.do?id=1070699&amp;sourceType=3</link>
            <description>CALGARY, ALBERTA--(Marketwire - Nov. 4, 2009) - 

ALL AMOUNTS ARE STATED IN U.S.$

Agrium Inc. (TSX:AGU) (NYSE:AGU) announced today net earnings of $26-million ($0.16 diluted earnings per share) for the third quarter of 2009, compared with the net earnings of $367-million in the third quarter of 2008 ($2.31 diluted earnings per share).

The 2009 third quarter results included gains of $5-million ($0.02 diluted earnings per share) on derivative financial instruments and a $25-million expense ($0.11 decrease in diluted earnings per share) in stock-based compensation. It also included an inventory write-down of $9-million (a $0.04 decrease in diluted earnings per share) primarily associated with our Wholesale purchase for resale business. Excluding these items, our net earnings would have been $46-million ($0.29 diluted earnings per share) for the third quarter of 2009.
</description>
            <category domain="http://www.marketwire.com/rss/stock">TSX:AGU</category>
            <category domain="http://www.marketwire.com/rss/stock">NYSE:AGU</category>
            <pubDate>Wed, 04 Nov 2009 07:00:00 EST</pubDate>
        </item>
        <item>
            <title>The Clorox Company Joins the Business Coalition for Workplace Fairness</title>
            <link>http://www.marketwire.com/mw/release.do?id=1071182&amp;sourceType=3</link>
            <description>&lt;p&gt;Supports Employment Nondiscrimination Act&lt;/p&gt;</description>
            <category domain="http://www.marketwire.com/rss/stock">NYSE:CLX</category>
            <pubDate>Tue, 03 Nov 2009 17:00:00 EST</pubDate>
        </item>
        <item>
            <title>Alta funcionalidad a su alcance: Las balanzas Serie FZ-i de A&amp;D Weighing</title>
            <link>http://www.marketwire.com/mw/release.do?id=1070247&amp;sourceType=3</link>
            <description>&lt;p&gt;SAN JOSE, CA--(Marketwire - November 3, 2009) -  A&amp;D Weighing se enorgullece en anunciar la
introducción de la Serie FZ-i de balanzas de precisión, con calibración
interna. La FZ-i tiene todas las características de alto rendimiento que
los usuarios han llegado a esperar de la Serie FX-i, más la adición de
calibración de un solo paso. Con solo presionar una tecla, usted puede
asegurar la precisión de su balanza.
&lt;p&gt;
Características importantes incluyen:
</description>
            <pubDate>Tue, 03 Nov 2009 13:15:00 EST</pubDate>
        </item>
        <item>
            <title>DSM delivers strong result improvement in Q3</title>
            <link>http://www.marketwire.com/mw/release.do?id=1069674&amp;sourceType=3</link>
            <description>&lt;p&gt;HEERLEN, NETHERLANDS--(Marketwire - November 3, 2009) - &lt;p&gt;
&lt;br&gt;
  * Q3 operating profit from continuing operations EUR 139
million,
    more than double Q2 2009 (EUR 58 million)
&lt;p&gt;
  * Strong Life Sciences performance due to robust Nutrition
business
&lt;p&gt;
  * Materials Sciences continued strong recovery
&lt;p&gt;
  * Cost savings and efficiency improvements on track to achieve
EUR
    150 - 200 million on yearly basis by 2010
&lt;p&gt;
  * Cash flow from operating activities again very strong (Q3 EUR
517
    million)
</description>
            <pubDate>Tue, 03 Nov 2009 02:08:00 EST</pubDate>
        </item>
        <item>
            <title>Lapolla Reports Record Third Quarter 2009 Results</title>
            <link>http://www.marketwire.com/mw/release.do?id=1069597&amp;sourceType=3</link>
            <description>&lt;p&gt;Delivers Operating Profit and Revenue Growth&lt;/p&gt;</description>
            <pubDate>Mon, 02 Nov 2009 17:54:00 EST</pubDate>
        </item>
        <item>
            <title>Clorox Delivers 23 Percent Earnings Growth in Q1, Driven by Robust Gross Margin Expansion</title>
            <link>http://www.marketwire.com/mw/release.do?id=1069063&amp;sourceType=3</link>
            <description>&lt;p&gt;OAKLAND, CA--(Marketwire - November 2, 2009) -  The Clorox Company (&lt;exchange name="NYSE"&gt;NYSE&lt;/exchange&gt;: &lt;ticker name="CLX"&gt;CLX&lt;/ticker&gt;) today reported
strong earnings growth, driven by robust gross margin expansion and modest
volume growth, for its first quarter, which ended Sept. 30.
&lt;p&gt;
"We had a great first quarter, especially given the continued challenging
economic environment and the impact of weaker foreign currencies," said
Chairman and CEO Don Knauss. "Most of our businesses performed well, and we
exceeded our earnings expectations due to strong sales of disinfecting
products related to the H1N1 flu pandemic. We also delivered our third
consecutive quarter of significant gross margin improvement."
</description>
            <category domain="http://www.marketwire.com/rss/stock">NYSE:CLX</category>
            <pubDate>Mon, 02 Nov 2009 08:30:00 EST</pubDate>
        </item>
        <item>
            <title>Clorox Announces Plans to Begin Transitioning U.S. Operations to High-Strength Bleach</title>
            <link>http://www.marketwire.com/mw/release.do?id=1069049&amp;sourceType=3</link>
            <description>&lt;p&gt;OAKLAND, CA--(Marketwire - November 2, 2009) -  The Clorox Company (&lt;exchange name="NYSE"&gt;NYSE&lt;/exchange&gt;: &lt;ticker name="CLX"&gt;CLX&lt;/ticker&gt;) today announced
that it plans to begin modifying manufacturing processes in its U.S. bleach
operations. The initiative calls for Clorox to begin transitioning from
chlorine to high-strength bleach as a raw material for making its namesake
bleach.
&lt;p&gt;
"This decision was driven by our commitment to strengthen our operations
and add another layer of security," said Chairman and CEO Don Knauss.
</description>
            <category domain="http://www.marketwire.com/rss/stock">NYSE:CLX</category>
            <pubDate>Mon, 02 Nov 2009 08:29:00 EST</pubDate>
        </item>
        <item>
            <title>Locus Offers Free GHG Calculator for CA Mandatory Reporting</title>
            <link>http://www.marketwire.com/mw/release.do?id=1068964&amp;sourceType=3</link>
            <description>&lt;p&gt;Industry Leader Takes Action to Help With GHG Reporting&lt;/p&gt;</description>
            <pubDate>Mon, 02 Nov 2009 07:00:00 EST</pubDate>
        </item>
        <item>
            <title>Flutiform EU Clinical Trial Successfully Completed</title>
            <link>http://www.marketwire.com/mw/release.do?id=1068887&amp;sourceType=3</link>
            <description>&lt;p&gt;LONDON--(Marketwire - November 2, 2009) -  &lt;pre&gt;

FOR IMMEDIATE RELEASE


SkyePharma Announces Successful Completion of

FlutiformTM EU Clinical Trial Programme


LONDON, UK, 2 November, 2009 - SkyePharma PLC (&lt;exchange name="LSE"&gt;LSE&lt;/exchange&gt;: &lt;ticker name="SKP"&gt;SKP&lt;/ticker&gt;) today
announces that its development and marketing partner Mundipharma
International Corporation Limited ("Mundipharma") has successfully
completed the final Phase III clinical study for the European
development programme for FlutiformTM, with the higher dose strength
study (FLT 3503) meeting its primary endpoints. This will enable the
regulatory filing with the European authorities to take place in Q1
2010 as planned.


Study FLT-3503 included 529 patients, who met the requirements for the"per
protocol" analysis, and were suffering from severe, persistent and
reversible asthma. They were treated in an eight week double-blind,
double dummy, randomised multiple centre four arm parallel group study
to assess t</description>
            <category domain="http://www.marketwire.com/rss/stock">LSE:SKP</category>
            <category domain="http://www.marketwire.com/rss/stock">NASDAQ:SKYE</category>
            <pubDate>Mon, 02 Nov 2009 05:24:00 EST</pubDate>
        </item>
        <item>
            <title>Lapolla and ABC's "Extreme Makeover: Home Edition" Lewisport, KY Project</title>
            <link>http://www.marketwire.com/mw/release.do?id=1068743&amp;sourceType=3</link>
            <description>&lt;p&gt;Mattingly Family Home Episode Airs Sunday, November 1, 2009 at 8/7c on ABC&lt;/p&gt;</description>
            <pubDate>Fri, 30 Oct 2009 18:37:00 EDT</pubDate>
        </item>
        <item>
            <title>DSM to further explore growth opportunities in China</title>
            <link>http://www.marketwire.com/mw/release.do?id=1068234&amp;sourceType=3</link>
            <description>&lt;p&gt;HEERLEN, NETHERLANDS--(Marketwire - October 30, 2009) - &lt;p&gt;
&lt;br&gt;
Royal DSM N.V., the global Life Sciences and Materials Sciences
company headquartered in the Netherlands, today announces that the
contracts to establish nutrition and anti-infectives joint ventures
in China with North China Pharmaceutical Group Corporation Ltd.
(NCPC) are suspended. DSM will continue its search for partners in
China as the company prepares for further growth in the country,
which in 2008 represented 8% of DSM's net sales.
</description>
            <pubDate>Fri, 30 Oct 2009 03:28:00 EDT</pubDate>
        </item>
    </channel>
</rss>